Callizo J, et al. - In this prospective, randomized, monocentric study, 32 cases were estimated to assess the impacts of intravitreal bevacizumab (BEV) with/without supplementary macular grid laser photocoagulation (GRID) for macular edema (ME) secondary to branch retinal vein occlusion (BRVO). They observed the profitable influence of bevacizumab in ME in eyes with BRVO. They noted a significant improvement in vision after a loading phase of 3 injections which continued at week 38. But, supplementary grid laser photocoagulation displayed no advantageous functional/anatomical impact and no reduction in number of injections. They observed an increase in the foveal avascular zone (FAZ) in all the cases.